EASL Liver Cancer Summit
Liver cancer is a major health problem and hepatocellular carcinoma (HCC) is considered one of the leading causes of cancer-related deaths worldwide. It is associated with many liver diseases such as Hepatitis...
EASL Liver Cancer Summit at a glance
Quick numbers to help you scope your booth strategy.
What to know about EASL Liver Cancer Summit
This specialized summit focuses on the intersection of hepatology and oncology, drawing a highly technical audience of clinical researchers and transplant surgeons. Unlike broader medical congresses, the floor is dominated by discussions on multidisciplinary care pathways and emerging systemic therapies, requiring booths to prioritize high-level clinical data over general brand awareness.
The EASL audience expects to speak with Medical Science Liaisons (MSLs) or clinical leads; standard sales representatives without deep therapeutic knowledge will struggle to engage this expert demographic.
In the French medical landscape, interactions are governed by the Loi Bertrand; ensure your lead capture and hospitality offerings are strictly compliant with French transparency regulations.
Digital posters and high-resolution imaging displays are standard; ensure your booth can facilitate small-group discussions around complex diagnostic charts or clinical trial endpoints.
Morning coffee and the afternoon poster sessions are the primary traffic drivers; locate your booth near the e-poster terminals if possible to capture the natural flow of scientific inquiry.
AI-generated overview · verify specifics with the official organizer
Exhibitors comparing EASL Liver Cancer Summit also look at
Similar shows by industry or city — useful if you're planning a multi-show year.